Progress updates of notable trials at EMUC18: What you need to know
November 10, 2018Read moreDevelopments of notable trials were announced today during Plenary Session 06 New trials update: What we need to know...
0Video: Update on PROSPER & SPARTAN Trials
November 10, 2018Read moreIn his lecture “Early hormonal manipulation in M0 CRPC”, Prof. Dr. Karim Fizazi (FR) stated that M0 CRPC is a rare situation...
Identifying the frail kidney cancer patient
November 9, 2018Read moreThe first day of EMUC18 came to a close with a session on kidney cancer, specifically on the frailty...
Video: Sequencing of novel therapies in urogenital malignancies
November 9, 2018Read moreDr. Sergio Bracarda (IT) highlights the key points on sequencing novel therapies from the perspective of treating patients with...
Deliberations on IO as first-line therapy for kidney cancer patients
November 9, 2018Read moreIn the point-counterpoint discussion “Immunotherapy for all patients as first line in kidney cancer?” in Plenary Session 04 “Immunotherapy:...
Video: Update on EAU Prostate Cancer Center consensus meeting
November 9, 2018Read moreProf. Dr. Peter Albers (DE) on the importance of specialised prostate cancer centres and where we are at this...
Video: Prostate cancer management: Implementation without good evidence?
November 9, 2018Read moreProf. James N’Dow talks about the most pressing evidence gaps in treating patients with prostate cancer and which technological...
The future of good evidence gathering for PCa
November 9, 2018Read moreNew approaches to clinical trials can lead to more successful results in the challenging near future. Parallel, comparative studies...
PCa management essentials opens EMUC’s 10th year
November 9, 2018Read moreThroughout a decade, the European Multidisciplinary Congress on Urological Cancers (EMUC) has established its reputation as the leading platform...
